Correlation Engine 2.0
Clear Search sequence regions


  • antitumor (2)
  • apoptosis (2)
  • c225 (2)
  • cancer (1)
  • cetuximab (4)
  • egfr protein, human (1)
  • ErbB (2)
  • glioma (5)
  • human (2)
  • hyperthermia (8)
  • mice nude (1)
  • near (3)
  • protein human (1)
  • receptors (2)
  • xenograft (1)
  • Sizes of these terms reflect their relevance to your search.

    Thermoresponsive nanoparticles have become an attractive candidate for designing combined multimodal therapy strategies because of the onset of hyperthermia and their advantages in synergistic cancer treatment. In this paper, novel cetuximab (C225)-encapsulated core-shell Fe3O4@Au magnetic nanoparticles (Fe3O4@Au-C225 composite-targeted MNPs) were created and applied as a therapeutic nanocarrier to conduct targeted magneto-photothermal therapy against glioma cells. The core-shell Fe3O4@Au magnetic nanoparticles (MNPs) were prepared, and then C225 was further absorbed to synthesize Fe3O4@Au-C225 composite-targeted MNPs. Their morphology, mean particle size, zeta potential, optical property, magnetic property and thermal dynamic profiles were characterized. After that, the glioma-destructive effect of magnetic fluid hyperthermia (MFH) combined with near-infrared (NIR) hyperthermia mediated by Fe3O4@Au-C225 composite-targeted MNPs was evaluated through in vitro and in vivo experiments. The inhibitory and apoptotic rates of Fe3O4@Au-C225 composite-targeted MNPs-mediated combined hyperthermia (MFH+NIR) group were significantly higher than other groups in vitro and the marked upregulation of caspase-3, caspase-8, and caspase-9 expression indicated excellent antitumor effect by inducing intrinsic apoptosis. Furthermore, Fe3O4@Au-C225 composite-targeted MNPs-mediated combined hyperthermia (MFH+NIR) group exhibited significant tumor growth suppression compared with other groups in vivo. Our studies illustrated that Fe3O4@Au-C225 composite-targeted MNPs have great potential as a promising nanoplatform for human glioma therapy and could be of great value in medical use in the future.

    Citation

    Qianling Lu, Xinyu Dai, Peng Zhang, Xiao Tan, Yuejiao Zhong, Cheng Yao, Mei Song, Guili Song, Zhenghai Zhang, Gang Peng, Zhirui Guo, Yaoqi Ge, Kangzhen Zhang, Yuntao Li. Fe3O4@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells. International journal of nanomedicine. 2018;13:2491-2505

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 29719396

    View Full Text